These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 32896551
1. Central endothelin ETB receptor activation reduces blood pressure and catecholaminergic activity in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats. Guil MJ, Soria C, Seijas M, Bianciotti LG, Vatta MS. Eur J Pharmacol; 2020 Oct 15; 885():173543. PubMed ID: 32896551 [Abstract] [Full Text] [Related]
2. Role of Brain Endothelin Receptor Type B (ETB) in the Regulation of Tyrosine Hydroxylase in the Olfactory Bulb of DOCA-Salt Hypertensive Rats. Cassinotti L, Guil M, Bianciotti L, Vatta M. Curr Vasc Pharmacol; 2023 Oct 15; 21(4):246-256. PubMed ID: 37349999 [Abstract] [Full Text] [Related]
3. Chronic Blockade of Brain Endothelin Receptor Type-A (ETA) Reduces Blood Pressure and Prevents Catecholaminergic Overactivity in the Right Olfactory Bulb of DOCA-Salt Hypertensive Rats. Cassinotti LR, Guil MJ, Schöller MI, Navarro MP, Bianciotti LG, Vatta MS. Int J Mol Sci; 2018 Feb 27; 19(3):. PubMed ID: 29495426 [Abstract] [Full Text] [Related]
4. Role of endothelin receptor type A on catecholamine regulation in the olfactory bulb of DOCA-salt hypertensive rats: Hemodynamic implications. Guil MJ, Schöller MI, Cassinotti LR, Biancardi VC, Pitra S, Bianciotti LG, Stern JE, Vatta MS. Biochim Biophys Acta Mol Basis Dis; 2019 Nov 01; 1865(11):165527. PubMed ID: 31398465 [Abstract] [Full Text] [Related]
5. Involvement of endothelins in deoxycorticosterone acetate-salt hypertension through the modulation of noradrenergic transmission in the rat posterior hypothalamus. Abramoff T, Guil MJ, Morales VP, Hope SI, Höcht C, Bianciotti LG, Vatta MS. Exp Physiol; 2015 Jun 01; 100(6):617-27. PubMed ID: 25809871 [Abstract] [Full Text] [Related]
6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL, Turgeon A, Deng LY. Br J Pharmacol; 1997 Jul 01; 121(5):935-40. PubMed ID: 9222550 [Abstract] [Full Text] [Related]
8. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. Circulation; 1995 Feb 15; 91(4):1229-35. PubMed ID: 7850963 [Abstract] [Full Text] [Related]
9. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T. Br J Pharmacol; 1995 Aug 15; 115(8):1377-81. PubMed ID: 8564194 [Abstract] [Full Text] [Related]
10. Local administration of ETA (but not ETB) blockers into the PAG area of the brain decreases blood pressure of DOCA-salt rats. Di Filippo C, D'Amico M, Piegari E, Rinaldi B, Filippelli A, Rossi F. Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug 15; 366(2):123-6. PubMed ID: 12122498 [Abstract] [Full Text] [Related]
11. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Larivière R, Sventek P, Thibault G, Schiffrin EL. Can J Physiol Pharmacol; 1995 Mar 15; 73(3):390-8. PubMed ID: 7544236 [Abstract] [Full Text] [Related]
12. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension. Johnson RJ, Galligan JJ, Fink GD. J Hypertens; 2001 Mar 15; 19(3):431-40. PubMed ID: 11288813 [Abstract] [Full Text] [Related]
13. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M. Hypertension; 1999 Feb 15; 33(2):759-65. PubMed ID: 10024341 [Abstract] [Full Text] [Related]
14. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS, Turgeon A, Schiffrin EL. Am J Hypertens; 1998 May 15; 11(5):554-62. PubMed ID: 9633791 [Abstract] [Full Text] [Related]
15. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS. Am J Physiol Renal Physiol; 2000 Feb 15; 278(2):F279-86. PubMed ID: 10662732 [Abstract] [Full Text] [Related]
17. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats. Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM. Clin Exp Pharmacol Physiol Suppl; 1995 Dec 15; 22(1):S188-90. PubMed ID: 9072349 [Abstract] [Full Text] [Related]
18. Enhanced assymetrical noradrenergic transmission in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats. Abramoff T, Guil MJ, Morales VP, Hope SI, Soria C, Bianciotti LG, Vatta MS. Neurochem Res; 2013 Oct 15; 38(10):2063-71. PubMed ID: 23888389 [Abstract] [Full Text] [Related]
19. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S. Br J Pharmacol; 1995 Mar 15; 114(5):925-30. PubMed ID: 7780646 [Abstract] [Full Text] [Related]